TrialNaunyn-Schmiedeberg's archives of pharmacology2019

A population pharmacokinetic model of intravenous telavancin in healthy individuals to assess tissue exposure.

Sami Ullah et al.PubMed ↗Publisher ↗

No numbers read from the abstract.